Anti-angiogenic efficacy of aflibercept and bevacizumab in primary oral squamous cell carcinoma cells.
Meysam GanjibakhshRoshanak MonshizadehAhmad NasimianPouyan AminishakibParvaneh FarzanehSahar Tavakoli ShirajiAta GharajeiSedigheh RahrotabanFereshteh BaghaeiNeda Sadat GohariPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2018)
The anti-angiogenic-targeted drugs, especially Af, might be effective in treatment of patients with OSCC in combination with conventional surgical treatments.